NEPHROGENEX INC COM
NRX
NRX was delisted on the 10th of May, 2016.
1 hedge funds and large institutions have $0 invested in NEPHROGENEX INC COM in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 16 closing their positions.
94% less funds holding
Funds holding: 17 → 1 (-16)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1.17M → $0 (-$1.17M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 16
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCP
Rho Capital Partners
New York
|
-$495K |
| 2 |
VAM
Visium Asset Management
New York
|
-$371K |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$184K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$35K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$19K |
NRX Hedge Fund Activity: Q2 2016 in Review
1 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in NEPHROGENEX INC COM (NRX) for Q2 2016, worth a combined $0 — down 100% from $1.17M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of NRX and 0 opened new positions — a net loss of 16 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Rho Capital Partners, exiting entirely with an estimated $495K sold.
- 1 institutional investor held NEPHROGENEX INC COM (NRX) as of Q2 2016, down from 17 in Q1 2016.
- Funds reported $0 of NEPHROGENEX INC COM stock for Q2 2016, down 100% quarter-over-quarter.
- 0 funds opened new NEPHROGENEX INC COM positions in Q2 2016 and 16 closed out, a net change of -16 holders.
- The largest NEPHROGENEX INC COM seller in Q2 2016 was Rho Capital Partners, an estimated $495K sold.
Based on aggregated 13F filings for Q2 2016.